These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 939324)
21. The effect of crystal forms of some barbiturates on their pharmaceutical properties. Part 1: Phenobarbitone. El-Banna HM; Ebian AR; Ismail AA Pharmazie; 1975 Jul; 30(7):455-60. PubMed ID: 1178762 [TBL] [Abstract][Full Text] [Related]
23. [Polymorphism of progesterone. II. Use of differential calorimetry in the study of crystalline forms]. Cameroni R; Gamberini G; Bernabei MT Farmaco Prat; 1973 Dec; 28(12):636-41. PubMed ID: 4771356 [No Abstract] [Full Text] [Related]
24. Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies. Sharma P; Zujovic ZD; Bowmaker GA; Marshall AJ; Denny WA; Garg S Int J Pharm; 2011 Apr; 408(1-2):138-51. PubMed ID: 21272627 [TBL] [Abstract][Full Text] [Related]
25. Solid state characterization of the anti-HIV drug TMC114: interconversion of amorphous TMC114, TMC114 ethanolate and hydrate. Van Gyseghem E; Stokbroekx S; de Armas HN; Dickens J; Vanstockem M; Baert L; Rosier J; Schueller L; Van den Mooter G Eur J Pharm Sci; 2009 Dec; 38(5):489-97. PubMed ID: 19782132 [TBL] [Abstract][Full Text] [Related]
26. Thermal and nonthermal physiochemical processes in nanoscale films of amorphous solid water. Smith RS; Petrik NG; Kimmel GA; Kay BD Acc Chem Res; 2012 Jan; 45(1):33-42. PubMed ID: 21627126 [TBL] [Abstract][Full Text] [Related]
27. Effect of counterions on the properties of amorphous atorvastatin salts. Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794 [TBL] [Abstract][Full Text] [Related]
29. Screening chemical and physical stability of drug substances. Berglund M; Byström K; Pérsson B J Pharm Biomed Anal; 1990; 8(8-12):639-43. PubMed ID: 2100600 [TBL] [Abstract][Full Text] [Related]
30. Rapid conversion of API hydrates to anhydrous forms in aqueous media. Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923 [TBL] [Abstract][Full Text] [Related]
32. Radiopaque contrast media. XLIII. Physicochemical properties of iodamide, an intravenous uro-angiographic contrast agent. Felder E; Pitrè D; Grandi M Farmaco Sci; 1977 Oct; 32(10):755-65. PubMed ID: 21810 [No Abstract] [Full Text] [Related]
33. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance. Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651 [TBL] [Abstract][Full Text] [Related]
34. Thermomechanical properties of amorphous saccharides: their role in enhancing pharmaceutical product stability. Franks F Biotechnol Genet Eng Rev; 1999; 16():281-92. PubMed ID: 10819083 [No Abstract] [Full Text] [Related]
39. [The stability of bromhexine and the structure of its degradation products]. Göber B; Lisowski H; Franke P Pharmazie; 1988 Jan; 43(1):23-6. PubMed ID: 3375295 [TBL] [Abstract][Full Text] [Related]
40. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. Kumar S; Burgess DJ Int J Pharm; 2014 May; 466(1-2):223-32. PubMed ID: 24614581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]